PDS Biotechnology Ownership
| PDSB Stock | USD 1.37 0.01 0.74% |
Shares in Circulation | First Issued 2016-03-31 | Previous Quarter 37 M | Current Value 37 M | Avarage Shares Outstanding 15.6 M | Quarterly Volatility 13.2 M |
PDS |
PDS Stock Ownership Analysis
The book value of the company was at this time reported as 0.6. The company recorded a loss per share of 1.17. PDS Biotechnology Corp last dividend was issued on the 18th of March 2019. The entity had 1:20 split on the 18th of March 2019. PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey. Pds Biotechnology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 22 people. To find out more about PDS Biotechnology Corp contact Frank BeduAddo at 800 208 3343 or learn more at https://www.pdsbiotech.com.Besides selling stocks to institutional investors, PDS Biotechnology also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different PDS Biotechnology's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align PDS Biotechnology's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
PDS Biotechnology Quarterly Liabilities And Stockholders Equity |
|
Roughly 3.0% of PDS Biotechnology Corp are currently held by insiders. Unlike PDS Biotechnology's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against PDS Biotechnology's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of PDS Biotechnology's insider trades
PDS Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as PDS Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PDS Biotechnology Corp backward and forwards among themselves. PDS Biotechnology's institutional investor refers to the entity that pools money to purchase PDS Biotechnology's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Integrys Wealth Advisors Llc | 2024-12-31 | 73.5 K | Two Sigma Investments Llc | 2024-12-31 | 65.7 K | Virtu Financial Llc | 2024-12-31 | 54.7 K | Ubs Group Ag | 2024-12-31 | 50.1 K | Vontobel Holding Ltd. | 2024-12-31 | 40 K | Marshall Wace Asset Management Ltd | 2024-12-31 | 39 K | Jane Street Group Llc | 2024-12-31 | 35.6 K | Bank Of New York Mellon Corp | 2024-12-31 | 29.3 K | Bank Of America Corp | 2024-12-31 | 26.9 K | Vanguard Group Inc | 2024-12-31 | 1.5 M | Blackrock Inc | 2024-12-31 | 523.1 K |
PDS Biotechnology Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific PDS Biotechnology insiders, such as employees or executives, is commonly permitted as long as it does not rely on PDS Biotechnology's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases PDS Biotechnology insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
PDS Biotechnology Outstanding Bonds
PDS Biotechnology issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. PDS Biotechnology Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most PDS bonds can be classified according to their maturity, which is the date when PDS Biotechnology Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US70462GAC24 Corp BondUS70462GAC24 | View | |
| US70462GAB41 Corp BondUS70462GAB41 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PDS Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PDS Biotechnology. If investors know PDS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PDS Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of PDS Biotechnology Corp is measured differently than its book value, which is the value of PDS that is recorded on the company's balance sheet. Investors also form their own opinion of PDS Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is PDS Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PDS Biotechnology's market value can be influenced by many factors that don't directly affect PDS Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PDS Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if PDS Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PDS Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.